Nuvation Bio Inc. (NUVB) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Nuvation Bio Inc. (NUVB): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 39/100 — a percentile rank of Nuvation Bio Inc.’s fundamentals against Manufacturing peers, weakest on management. A quality ranking, not a price prediction.
| Market cap | $2.0B |
| P / S | 11.5× |
| EV / EBITDA | -14.5× |
| Gross margin | 89.4% |
| Operating margin | -80.8% |
| Net margin | -88.2% |
| Return on equity | -59.0% |
| ROIC | -53.4% |
| Revenue growth | 1083.6% |
| Debt / equity | 1.0× |
| Dividend yield | 0.0% |
Is Nuvation Bio Inc. overvalued? P/S looks fair vs its 5-year range; P/B looks overvalued vs its 5-year range.
Independent of the events above — derived from Nuvation Bio Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact